PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2023

Rhea-AI Summary

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) will host a business update conference call and webcast on November 15, 2023, at 8:30 AM EST. The call will provide a business update and overview of operations and growth strategy by Lishan Aklog, M.D., Chairman and CEO. Dennis McGrath, President and CFO, will discuss the third-quarter 2023 financial results. The webcast will be available on the company's website. Replay will be available for 30 days.

Conference Call and Webcast at 8:30 AM Eastern Time

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Wednesday, November 15, 2023, at 8:30 AM EST. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update including an overview of the Company's operations and growth strategy. In addition, Dennis McGrath, PAVmed's President and Chief Financial Officer, will discuss the Company's third-quarter 2023 financial results.

The webcast will be available at the investor relations section of the Company's website at pavmed.com.  Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-833-816-1419 and international listeners should dial 1-412-317-0512. All listeners should provide the operator with the conference call name "PAVmed Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.

About PAVmed

PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its majority-owned subsidiary, Lucid Diagnostics Inc. (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard^® Esophageal DNA Test and EsoCheck^® Esophageal Cell Collection Device—the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients. Its other majority-owned subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.

For more and for more information about PAVmed, please visit pavmed.com.

For more information about Lucid Diagnostics, please visit luciddx.com.

For more information about Veris Health, please visit verishealth.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-a-business-update-conference-call-and-webcast-on-november-15-2023-301974198.html

SOURCE PAVmed Inc.

FAQ

When is PAVmed's business update conference call and webcast?

The conference call and webcast will take place on November 15, 2023, at 8:30 AM EST.

Who will provide the business update during the call?

Lishan Aklog, M.D., PAVmed's Chairman and CEO, will provide the business update.

What will be discussed during the call?

The call will include an overview of the company's operations and growth strategy.

Who will discuss the financial results?

Dennis McGrath, PAVmed's President and CFO, will discuss the third-quarter 2023 financial results.

Where can the webcast be accessed?

The webcast will be available on the investor relations section of PAVmed's website at pavmed.com.

How can I access the conference call by telephone?

U.S.-based callers should dial 1-833-816-1419 and international listeners should dial 1-412-317-0512. Provide the operator with the conference call name 'PAVmed Business Update' to join.

How long will the replay be available?

The replay will be available for 30 days on the investor relations section of PAVmed's website at pavmed.com.